Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...

Dupilumab is designed to treat asthma by targeting specific pathways involved in the inflammatory process. This Phase 3 study is interventional and randomized, employing a parallel assignment ...

While biological drugs or biologics have improved the lives of many people with severe asthma, a new study shows that some immune cells with high inflammatory potential are not completely eradicated ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.